Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 1205340)

Published in Haemostasis on January 01, 1975

Authors

M Dechavanne, D Ville, J J Viala, A Kher, J Faivre, M B Pousset, H Dejour

Articles by these authors

(truncated to the top 100)

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78

Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02

Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26

Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. Methods Inf Med (1998) 2.80

Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74

Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25

[Patella infera. Apropos of 128 cases]. Rev Chir Orthop Reparatrice Appar Mot (1982) 2.12

Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96

Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88

Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum (2001) 1.87

Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76

Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine. Indian J Gastroenterol (1998) 1.68

Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67

Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol (1995) 1.65

Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) Gastroenterology (1998) 1.62

Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61

Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59

How to ensure data security of an epidemiological follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inform (1998) 1.58

Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther (2005) 1.58

Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50

Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg (2002) 1.48

European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44

The syndrome of abnormal chromatin clumping in leucocytes: a myelodysplastic disorder with proliferative features? Br J Haematol (1988) 1.42

Serum thymidine kinase in acute nonlymphoblastic leukemia. Leukemia (1988) 1.41

[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]. Gastroenterol Clin Biol (1991) 1.40

[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]. Rev Epidemiol Sante Publique (2002) 1.39

Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39

Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39

Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38

Acute myelogenous leukaemia following exposure to microwaves. Br J Haematol (1989) 1.38

Prevention of venous thrombosis after elective hip surgery. Orthopedics (1998) 1.38

Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer (2001) 1.38

[A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter]. Rev Mal Respir (2002) 1.37

[Disposable versus reusable biopsy forceps. A prospective cost analysis in the gastrointestinal endoscopy unit of the Dijon University Hospital]. Gastroenterol Clin Biol (2001) 1.37

Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34

Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34

Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34

Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer (2006) 1.33

Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32

Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer (1998) 1.29

Adenoma--carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer (1992) 1.28

European health systems and cancer care. Ann Oncol (2003) 1.27

A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26

Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25

Pseudoachondroplastic dysplasia. J Postgrad Med (1994) 1.24

[Arthrosis of the knee in chronic anterior laxity]. Rev Chir Orthop Reparatrice Appar Mot (1987) 1.23

Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer (2000) 1.22

Pseudomembranous colitis probably due to rifampicin. Lancet (1980) 1.22

[Letter: Peripheral neuropathy after prolonged adsorption of perhexiline maleate. 2 cases]. Nouv Presse Med (1975) 1.20

Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18

Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg (2008) 1.17

Influence of socioeconomic status on prognosis of colorectal cancer. A population-based study in Côte D'Or, France. Cancer (1993) 1.14

Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13

Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12

[Factors of early prognosis in medically treated haemorrhages of upper gastrointestinal tract in cirrhotic patients. Statistical study (author's transl)]. Pathol Biol (Paris) (1981) 1.12

Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer (1997) 1.12

Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer (2001) 1.12

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg (2000) 1.11

Long-term anticoagulant therapy in patients with coronary artery disease. Eur Heart J (2006) 1.11

Comparability of colorectal cancer survival data in three European population-based registries. Eur J Cancer Prev (1998) 1.11

Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol (2005) 1.11

Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev (1997) 1.10

What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers. Am J Surg Pathol (2004) 1.10

Modelling time-dependent hazard ratios in relative survival: application to colon cancer. J Clin Epidemiol (2001) 1.08

Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08

Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08

Management and prognosis of pancreatic cancer over a 30-year period. Br J Cancer (2009) 1.07

Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett (2011) 1.05

Haematopoietic malignancies in Côte d'Or (France): a population based study. Br J Cancer (1986) 1.03

One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res (1985) 1.03

Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol (2005) 1.03

[Unreduced posterior luxations and fractures-luxations of the shoulder. Apropos of 30 cases]. Rev Chir Orthop Reparatrice Appar Mot (1990) 1.01

Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut (1995) 1.01

Prognosis of gastric carcinoma after curative surgery. A population-based study using multivariate crude and relative survival analysis. Dig Dis Sci (1992) 1.01

Oesophageal cancer in France: potential importance of hot alcoholic drinks. Int J Cancer (1997) 1.00

Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99

Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99

Are there regional differences in the management of colon cancer in France? Eur J Cancer Prev (2005) 0.98

Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76  TeV. Phys Rev Lett (2012) 0.98

Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen (1997) 0.98

Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer (2000) 0.97

The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis (1998) 0.97

Cancer registries: their interest and practical problems. Eff Health Care (1983) 0.97

[Letter: Cholostatic jaundice caused by carbimazole]. Nouv Presse Med (1973) 0.97

Evidence of improving survival of patients with rectal cancer in france: a population based study. Gut (1999) 0.97

Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group. World J Surg (2001) 0.97

Anterior cruciate reconstruction combined with valgus upper tibial osteotomy: 12 years follow-up. Knee (2004) 0.96

Complex formation of human thrombospondin with osteonectin. Eur J Biochem (1988) 0.96

Laboratory assessment of antithrombotic therapy: what tests and if so why? Haemostasis (1998) 0.96

Results of partial meniscectomy related to the state of the anterior cruciate ligament. Review at 20 to 35 years. J Bone Joint Surg Br (1993) 0.96

Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum (1998) 0.96

Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95

Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group. Thromb Haemost (1994) 0.95

Management and prognosis of esophageal cancers: has progress been made? Eur J Cancer (2005) 0.95

Modeling recurrence in colorectal cancer. J Clin Epidemiol (2004) 0.93

Influence of dietary factors on colorectal cancer survival. Gut (2003) 0.93

Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93

Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. Phys Rev Lett (2003) 0.93